Literature DB >> 23707953

Ephrin-A1/EphA4-mediated adhesion of monocytes to endothelial cells.

Stefanie Jellinghaus1, David M Poitz, Georg Ende, Antje Augstein, Sönke Weinert, Beryl Stütz, Rüdiger C Braun-Dullaeus, Elena B Pasquale, Ruth H Strasser.   

Abstract

The Eph receptors represent the largest family of receptor tyrosine kinases. Both Eph receptors and their ephrin ligands are cell-surface proteins, and they typically mediate cell-to-cell communication by interacting at sites of intercellular contact. The major aim of the present study was to investigate the involvement of EphA4-ephrin-A1 interaction in monocyte adhesion to endothelial cells, as this process is a crucial step during the initiation and progression of the atherosclerotic plaque. Immunohistochemical analysis of human atherosclerotic plaques revealed expression of EphA4 receptor and ephrin-A1 ligand in major cell types within the plaque. Short-time stimulation of endothelial cells with the soluble ligand ephrin-A1 leads to a fourfold increase in adhesion of human monocytes to endothelial cells. In addition, ephrin-A1 further increases monocyte adhesion to already inflamed endothelial cells. EphrinA1 mediates its effect on monocyte adhesion via the activated receptor EphA4. This ephrinA1/EphA4 induced process involves the activation of the Rho signaling pathway and does not require active transcription. Rho activation downstream of EphA4 leads to increased polymerization of actin filaments in endothelial cells. This process was shown to be crucial for the proadhesive effect of ephrin-A1. The results of the present study show that ephrin-A1-induced EphA4 forward signaling promotes monocyte adhesion to endothelial cells via activation of RhoA and subsequent stress-fiber formation by a non-transcriptional mechanism.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adhesion; Atherosclerosis; Endothelium; Ephrin; Monocytes

Mesh:

Substances:

Year:  2013        PMID: 23707953     DOI: 10.1016/j.bbamcr.2013.05.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

1.  EphA2 stimulates VCAM-1 expression through calcium-dependent NFAT1 activity.

Authors:  Steven Daniel Funk; Alexandra C Finney; Arif Yurdagul; Christopher B Pattillo; A Wayne Orr
Journal:  Cell Signal       Date:  2018-05-21       Impact factor: 4.315

Review 2.  Monocyte trafficking across the vessel wall.

Authors:  Teresa Gerhardt; Klaus Ley
Journal:  Cardiovasc Res       Date:  2015-05-19       Impact factor: 10.787

3.  Activation of EphA4 induced by EphrinA1 exacerbates disruption of the blood-brain barrier following cerebral ischemia-reperfusion via the Rho/ROCK signaling pathway.

Authors:  Fangbin Chen; Zhiyang Liu; Wei Peng; Zhiqin Gao; Hui Ouyang; Tongjun Yan; Songbai Ding; Zhankui Cai; Bin Zhao; Longjin Mao; Zhiyong Cao
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

4.  EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.

Authors:  Alexandra C Finney; Steven D Funk; Jonette M Green; Arif Yurdagul; Mohammad Atif Rana; Rebecca Pistorius; Miriam Henry; Andrew Yurochko; Christopher B Pattillo; James G Traylor; Jin Chen; Matthew D Woolard; Christopher G Kevil; A Wayne Orr
Journal:  Circulation       Date:  2017-05-09       Impact factor: 29.690

Review 5.  Integrin signaling in atherosclerosis.

Authors:  Alexandra C Finney; Karen Y Stokes; Christopher B Pattillo; A Wayne Orr
Journal:  Cell Mol Life Sci       Date:  2017-02-28       Impact factor: 9.261

Review 6.  Eph receptors and ephrins: therapeutic opportunities.

Authors:  Antonio Barquilla; Elena B Pasquale
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-03       Impact factor: 13.820

Review 7.  Ephs and Ephrins in malignant gliomas.

Authors:  Sara Ferluga; Waldemar Debinski
Journal:  Growth Factors       Date:  2014-11-24       Impact factor: 2.511

8.  PADPIN: protein-protein interaction networks of angiogenesis, arteriogenesis, and inflammation in peripheral arterial disease.

Authors:  Liang-Hui Chu; Chaitanya G Vijay; Brian H Annex; Joel S Bader; Aleksander S Popel
Journal:  Physiol Genomics       Date:  2015-06-09       Impact factor: 3.107

Review 9.  Current siRNA targets in atherosclerosis and aortic aneurysm.

Authors:  Leena Pradhan-Nabzdyk; Chenyu Huang; Frank W LoGerfo; Christoph S Nabzdyk
Journal:  Discov Med       Date:  2014-05       Impact factor: 2.970

10.  Expression of the Receptor Tyrosine Kinase EphB2 on Dendritic Cells Is Modulated by Toll-Like Receptor Ligation but Is Not Required for T Cell Activation.

Authors:  Patrice N Mimche; Lauren M Brady; Shirley Keeton; David S J Fenne; Thayer P King; Kendra M Quicke; Lauren E Hudson; Tracey J Lamb
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.